Principal Scientist, Early DCT Lead
Merck & Co., Inc. - USA - New Jersey - Rahway
Posted Nov 6, 2026
Benefits
- Parental leave
- Not verified
- Non-birth-parent leave
- Not verified
- Family-building benefits
-
- Fertility benefits: Not verified
- Adoption assistance: Not verified
- Surrogacy assistance: Not verified
- Mental health support
- Not verified
- Relocation assistance
- Not verified
- Childcare support
- Not verified
- Learning budget
- Not verified
- Verification
- Not verified checked Nov 20, 2026
- Salary
- $173K-$273K From the posting source checked Nov 16, 2026
- 401(k) match
- Reported from DOL Form 5500 industry filing (not employer-specific)
Was this benefit information wrong? Tell us.
Role
- Seniority
- Principal From the posting source checked Nov 16, 2026
Schedule
- Shift type
- Not verified
- Weekend work
- Not verified
Company
- Equity
- Offered Verified - SEC 10-K source checked Nov 16, 2026
Application
- Cover letter
- Not verified
- Assessment
- Not verified
- Deadline
- Not stated
Where they hire
State eligibility is not yet verified.
About this role
Principal Scientist, Early DCT Lead USA - New Jersey - Rahway Job Description Position Overview Large Molecule Drug Substance Development is seeking an accomplished scientific leader to direct the strategy and execution of biologics drug substance programs at our Rahway, New Jersey site. This highly visible position combines cross-functional CMC program leadership with deep expertise in cell line, upstream, and downstream process development; scale-up; technology transfer; and clinical manufacturing. The leader will advance assigned biologics from candidate selection through early clinical development and First-in-Human (FIH) milestones while establishing robust, phase-appropriate processes that enable late-stage development and commercialization. The role is accountable for the drug substance manufacturing process development and in-process control strategies, transfer process to GMP manufacturing sites, and reliable delivery of clinical drug substance supply. The successful candidate will be an enterprise-minded matrix leader who combines sound scientific judgment with disciplined execution. This individual will align cross-functional teams, anticipate and mitigate program risks, communicate clearly with senior stakeholders, and deliver innovative, scalable, and compliant drug substance solutions. Primary Responsibilities: Integrated CMC Program Leadership (DCT Lead): Program Accountability: Lead assigned early-stage Development and Commercialization Teams (DCTs), with accountability for integrated CMC strategy, milestone readiness, cross-functional alignment, and advancement through governance decisions. Operating Model Execution: Establish and lead matrixed CMC teams with clear structures, working groups, decision rights, timelines, escalation paths, and functional accountability. Cross-Functional Alignment: Coordinate strategy and execution across Drug Substance, Drug Product, Analytical Development, Regulatory Affairs, Quality Assurance, Global Supply Chain, pilot and commercial manufacturing, and external partners.
Read the full description at msd.wd5.myworkdayjobs.com. FewerJobs shows a preview and links to the original posting.
Apply link verified; last checked Nov 20, 2026.
What verified means
Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.
Related jobs
Principal Scientist, Early DCT Lead
Merck & Co., Inc. - USA - New Jersey - Rahway
Principal Scientist, Chemical Development
Immunome Inc - Bothell, Washington, United States
Site MS&T Head SMO - Drug Substance
Novartis - Morrisville (North Carolina)
Associate Director, Drug Substance
Relay Therapeutics Inc - Cambridge, MA